Diosmetin Modulates EMT-Associated Plasticity and Fibroblast-Activation Markers in Parallel Breast Cancer In Vitro Models
Molecules · 16.06.2026 · 31 (12) · 2111
DOI: 10.3390/molecules31122111 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 16.06.2026. Verfasst von Monika Michalczyk und 9 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, Medical University of Lublin, 7 Chodzki Street, 20-093 Lublin, Poland. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Breast Neoplasms, Flavonoids, Cancer-Associated Fibroblasts. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lublin.
Abstract (Originalsprache)
Metastasis remains the leading cause of mortality in breast cancer and is closely linked to epithelial–mesenchymal transition (EMT) and tumor microenvironment (TME)-associated processes. Diosmetin (DT), the active metabolite of diosmin, a widely used venoactive drug, has emerged as a potential anticancer agent. Building on our previous findings demonstrating that DT enhances doxorubicin efficacy, this study investigated its effects on tumor cell plasticity and stromal activation-associated responses. EMT was induced in MCF-7 cells, while a stromal model was established by TGF-β-mediated activation of BJ fibroblasts toward a cancer-associated fibroblast (CAF)-like phenotype. Additionally, doxorubicin-induced senescence was generated in fibroblasts. Migration assays and quantitative real-time PCR were used to assess functional and transcriptional changes. EMT induction resulted in decreased CDH1 expression and increased levels of VIM, MMP2, MMP9, IL-6, and HIF-1A, accompanied by enhanced migratory activity. DT attenuated TGF-β-induced CAF-like activation, as reflected by reduced expression of ACTA2, HGF, MMP2, MMP9, and IL6, and modulated hyaluronan turnover-related genes. Moreover, DT partially alleviated selected senescence-associated features in doxorubicin-treated fibroblasts. Collectively, these findings indicate that DT modulates EMT-associated plasticity and stromal activation-related responses in parallel in vitro models. Given its origin as a metabolite of a clinically used compound and its previously demonstrated chemosensitizing properties, DT may warrant further investigation as a potential adjunctive agent to modulate tumor- and stromal-associated processes in breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Doctoral School, Medical University of Lublin, 7 Chodzki Street, 20-093 Lublin, Poland.
- Independent Medical Biology Unit, Faculty of Pharmacy, Medical University of Lublin, 8b Jaczewskiego Street, 20-090 Lublin, Poland.
- Department of Pharmacognosy with Medicinal Plants Garden, Faculty of Pharmacy, Medical University of Lublin, 1 Chodzki Street, 20-093 Lublin, Poland.
- Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, 6 Chodzki Street, 20-093 Lublin, Poland.
- Department of Physiology and Toxicology, Institute of Medical Science, Faculty of Medicine, John Paul II Catholic University of Lublin, 1H Konstantynow, 20-708 Lublin, Poland.
- Human Anatomy Department, Faculty of Medicine, Medical University of Lublin, 4 Jaczewskiego Street, 20-090 Lublin, Poland.
ORCID-Profile: Joanna Kubik, Aleksandra Józefczyk, Magdalena Iwan, Ewelina Humeniuk, Grzegorz Adamczuk, Barbara Madej-Czerwonka, Maciej Czerwonka, Agnieszka Korga-Plewko
Förderung
- Medical University of Lublin
Zitieren
APA
Michalczyk, M., Kubik, J., Józefczyk, A., Iwan, M., Humeniuk, E., Adamczuk, G., Michalczuk, M., Madej-Czerwonka, B., Czerwonka, M., & Korga-Plewko, A. (2026). Diosmetin Modulates EMT-Associated Plasticity and Fibroblast-Activation Markers in Parallel Breast Cancer In Vitro Models. Molecules, 31(12), 2111. https://doi.org/10.3390/molecules31122111
Vancouver
Michalczyk M, Kubik J, Józefczyk A, Iwan M, Humeniuk E, Adamczuk G, et al. Diosmetin Modulates EMT-Associated Plasticity and Fibroblast-Activation Markers in Parallel Breast Cancer In Vitro Models. Molecules. 2026;31(12):2111. doi:10.3390/molecules31122111
BibTeX
@article{Michalczyk2026,
author = {Michalczyk, Monika and Kubik, Joanna and Józefczyk, Aleksandra and Iwan, Magdalena and Humeniuk, Ewelina and Adamczuk, Grzegorz and Michalczuk, Mariola and Madej-Czerwonka, Barbara and Czerwonka, Maciej and Korga-Plewko, Agnieszka},
title = {Diosmetin Modulates EMT-Associated Plasticity and Fibroblast-Activation Markers in Parallel Breast Cancer In Vitro Models},
journal = {Molecules},
year = {2026},
volume = {31},
number = {12},
pages = {2111},
doi = {10.3390/molecules31122111}
}
EUVIMED